TY - JOUR
T1 - COX-2 plays a role in angiogenic DBA+ uNK cell subsets activation and pregnancy protection in LPS-exposed mice
AU - Zavan, Bruno
AU - De Almeida, Eliana Martins
AU - Salles, Évila Da Silva Lopes
AU - Do Amarante-Paffaro, Andréa Mollica
AU - Paffaro, Valdemar Antonio
N1 - Funding Information:
This work was funded by grants from the FAPEMIG (Proc. No: CBB-APQ-02035-12 and CBB-APQ-01676-13 ), CAPES (Pró-equipamentos/ 2011 ), and FINEP (LABSBIOEX- 0336/09 ). ZAVAN, B. received a PhD scholarship from FAPEMIG. DE ALMEIDA, E. M. received an undergraduate scholarship from PIBIC/CNPq and Sallles, E. S. L received a MS scholarship from FAPEMIG.
Publisher Copyright:
© 2016 Elsevier Ltd.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Introduction Although uterine Natural Killer (uNK) cells have cytoplasmic granules rich in perforin and granzymes, these cells do not degranulate in normal pregnancy. DBA lectin+ uNK cells produce angiogenic factors which stimulate remodeling of uterine arterioles to increase blood flow within the growing feto-placental unit. We sought to investigate the importance of COX-2 on mouse pregnancy inoculated with Gram-negative bacteria Lipopolysaccharide (LPS) by treating with a selective COX-2 inhibitor (nimesulide). Methods We have combined histochemical, immunohistochemical, stereological, morphometric, behavioral, and litter analyses to investigate mouse pregnancy inoculated with LPS with or without pre-treatment with nimesulide 30 min before LPS injections, focusing on DBA+ uNK cell response and viability of the pregnancy. Results LPS caused sickness behavior, an immature DBA+ uNK influx, decreased mature DBA+ uNK cell numbers, and triggered a new DBAlow uNK appearance. These effects of LPS, except the sickness behavior, were prevented by nimesulide. COX-2 inhibition also prevented the down-regulation of uNK perforin and spiral arteriole α-actin expression stimulated by LPS. While the litter size from Nimesulide + LPS-treated mothers was significantly smaller compared to those from LPS-treated group, nimesulide alone showed no effect on the offspring. Discussion Collectively, our data indicate that COX-2 changes angiogenic DBA+ uNK cells in order to protect mouse pregnancy after LPS injection.
AB - Introduction Although uterine Natural Killer (uNK) cells have cytoplasmic granules rich in perforin and granzymes, these cells do not degranulate in normal pregnancy. DBA lectin+ uNK cells produce angiogenic factors which stimulate remodeling of uterine arterioles to increase blood flow within the growing feto-placental unit. We sought to investigate the importance of COX-2 on mouse pregnancy inoculated with Gram-negative bacteria Lipopolysaccharide (LPS) by treating with a selective COX-2 inhibitor (nimesulide). Methods We have combined histochemical, immunohistochemical, stereological, morphometric, behavioral, and litter analyses to investigate mouse pregnancy inoculated with LPS with or without pre-treatment with nimesulide 30 min before LPS injections, focusing on DBA+ uNK cell response and viability of the pregnancy. Results LPS caused sickness behavior, an immature DBA+ uNK influx, decreased mature DBA+ uNK cell numbers, and triggered a new DBAlow uNK appearance. These effects of LPS, except the sickness behavior, were prevented by nimesulide. COX-2 inhibition also prevented the down-regulation of uNK perforin and spiral arteriole α-actin expression stimulated by LPS. While the litter size from Nimesulide + LPS-treated mothers was significantly smaller compared to those from LPS-treated group, nimesulide alone showed no effect on the offspring. Discussion Collectively, our data indicate that COX-2 changes angiogenic DBA+ uNK cells in order to protect mouse pregnancy after LPS injection.
KW - Cyclooxygenase
KW - Dolichos Biflorus agglutinin lectin
KW - Inflammation
KW - LPS
KW - Nimesulide
KW - Uterine natural killer
UR - http://www.scopus.com/inward/record.url?scp=84975073400&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84975073400&partnerID=8YFLogxK
U2 - 10.1016/j.placenta.2016.06.006
DO - 10.1016/j.placenta.2016.06.006
M3 - Article
C2 - 27452436
AN - SCOPUS:84975073400
SN - 0143-4004
VL - 44
SP - 34
EP - 45
JO - Placenta
JF - Placenta
ER -